A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society

A cost-effectiveness analysis of capecitabine maintenance therapy versus routine follow-up for early-stage triple-negative breast cancer patients after standard treatment from a perspective of Chinese society

Abstract Background Capecitabine maintenance therapy is safe and efficacious for early-stage triple-negative breast cancer (TNBC) patients, but the cost-effectiveness of its long-term use has not been investigated. Here, we evaluated the cost-effectiveness of capecitabine maintenance therapy, compar...

Full description

Bibliographic Details
Main Authors: Ji-Bin Li, Zhuo-Chen Lin, Martin C. S. Wong, Harry H. X. Wang, Mengmeng Li, Su Li
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Medicine
Subjects:
Cost-effectiveness
Quality-adjusted life years
Capecitabine maintenance therapy
Early-stage triple-negative breast cancer
Online Access:https://doi.org/10.1186/s12916-022-02516-9

Internet

https://doi.org/10.1186/s12916-022-02516-9

Similar Items